Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NASDAQ:MDGN)

5.00
Delayed Data
As of Dec 02
 -0.06 / -1.19%
Today’s Change
3.09
Today|||52-Week Range
7.18
-16.94%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 12.50, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +150.00% increase from the last price of 5.00.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$0.00
Reporting Date
Mar 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.45%
 
 
 
 
 
 
Growthannually 12.76%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.